Anyone discouraged by the continued absence of a prostate cancer screening programme, the difficulties in getting a clear ...

Can PSA derivatives reduce unnecessary prostate MRI after negative biopsy? Learn how simple markers may guide imaging ...

The phase three clinical trial reached a milestone with its first American participant receiving treatment, advancing ...

Prostate cancer has now become the most prevalent cancer across the UK, new analysis reveals, surpassing breast cancer as the ...

Prostate cancer has overtaken breast cancer to become the most common form of the disease in the UK for the first time.

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the first patient in the United States (U.S.) has been dosed in BiPASS™ (Bi opsy of the P rostate A voidance S ...

Prostate cancer is now the most common cancer in the UK, according to a new analysis. Figures examined by the charity ...

In the first-ever study, Australian researchers have demonstrated the feasibility and safety of using stabilised hyaluronic ...

Prostate Cancer UK said a 42 per cent rise in diagnoses in the past decade is thanks to increased awareness of the disease by ...

Mount Sinai advances prostate care with AI-powered therapy designed to preserve continence and sexual function The Mount Sinai Hospital is ranked ...

Olympic legend Sir Chris Hoy says ‘we need more men to be diagnosed with prostate cancer early to stop them getting news I ...

"This study is a world-first in exploring stabilised hyaluronic acid (sHA) gel's potential to improve outcomes for patients ...